secwatch / observer
8-K filed April 8, 2022, 7:59 PM ET ticker CYTK CIK 0001061983
leadership confidence high sentiment neutral materiality 0.35

Cytokinetics appoints Robert Harrington as director; Dr. Gage resigns, Henderson becomes Chairman

CYTOKINETICS INC

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

L. Patrick Gage

Director
CYTK · CYTOKINETICS INC
Effective
2022-04-08
Filed
April 8, 2022, 7:59 PM ET
Also on the Effective Date, L. Patrick Gage, Ph.D. resigned as a director of Cytokinetics.
Appointed

Robert A. Harrington

Director
CYTK · CYTOKINETICS INC
Effective
2022-04-08
Filed
April 8, 2022, 7:59 PM ET
On April 8, 2022, (the “Effective Date”), the Board of Directors (the “Board”) of Cytokinetics, Incorporated (the “Company”) appointed, upon the recommendation of the Nominating and Governance Committee of the Board, Robert A. Harrington, M.D. to fill a vacant Board seat and to serve as a member of the Board with an initial term expiring at the Company’s 2024 annual meeting of stockholders.
Role change

John T. Henderson

Chairman of the Board
CYTK · CYTOKINETICS INC
Effective
2022-04-08
Filed
April 8, 2022, 7:59 PM ET
As a result of Dr. Gage’s resignation, John T. Henderson, M.D. was appointed as Chairman of the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

L. Patrick Gage resigned as Director at CYTOKINETICS INC.

Action
resigned
Role
Director
Exact text from the filing
Also on the Effective Date, L. Patrick Gage, Ph.D. resigned as a director of Cytokinetics.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Robert A. Harrington was appointed as Director at CYTOKINETICS INC.

Action
appointed
Role
Director
Exact text from the filing
On April 8, 2022, (the “Effective Date”), the Board of Directors (the “Board”) of Cytokinetics, Incorporated (the “Company”) appointed, upon the recommendation of the Nominating and Governance Committee of the Board, Robert A. Harrington, M.D. to fill a vacant Board seat and to serve as a member of the Board with an initial term expiring at the Company’s 2024 annual meeting of stockholders.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

John T. Henderson was appointed as Chairman of the Board at CYTOKINETICS INC.

Action
appointed
Role
Chairman of the Board
Exact text from the filing
As a result of Dr. Gage’s resignation, John T. Henderson, M.D. was appointed as Chairman of the Board.
View on SEC.gov

CYTOKINETICS INC filing history →

Source: SEC EDGAR
accession 0001171843-22-002480
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.